Global Health Limited , the operator of Medanta hospitals, has reported strong financial results for the first quarter of fiscal year 2026, demonstrating significant growth in both revenue and profitability.

Financial Highlights

• Revenue from operations increased by 19.6% year-over-year to ₹10,308.37 crore
• Consolidated net profit jumped 49.6% to ₹1,589.82 crore
• EBITDA rose to ₹2,270.00 crore, up from ₹1,860.00 crore in the same period last year
• EBITDA margin improved to 22.02% from 21.64% year-over-year

The company's robust performance was driven by enhanced operational efficiency alongside revenue growth across its healthcare services.

Operational Performance

Global Health continued to strengthen its position in the healthcare sector during the quarter. The company's focus on delivering high-quality medical services and expanding its reach has contributed to the strong financial results.

Management Commentary

While specific management comments were not provided, the significant improvement in financial metrics suggests that Global Health's strategic initiatives and operational excellence are yielding positive results.

Future Outlook

The company appears well-positioned for continued growth, with plans for expansion and improvement of its healthcare facilities. During the quarter, Global Health received an offer to acquire a land parcel in Guwahati, Assam, for establishing a super specialty hospital, indicating its commitment to expanding its presence in different regions.

Corporate Governance

The Board of Directors has recommended the re-appointment of key personnel, including Dr. Naresh Trehan as Chairman and Managing Director, and Mr. Vikram Singh Mehta and Mr. Hari Shanker Bhartia as Independent Directors, subject to shareholder approval. These reappointments reflect the company's focus on maintaining strong leadership and corporate governance.

Global Health's impressive Q1 FY2026 results demonstrate its resilience and growth potential in the competitive healthcare sector. With a strong financial foundation and strategic expansion plans, the company is well-equipped to capitalize on the growing demand for quality healthcare services in India.

Global Health Limited , the operator of Medanta hospitals, has reported robust financial performance for the first quarter of fiscal year 2026, alongside significant corporate governance updates.

Financial Highlights

Global Health's consolidated revenue from operations for Q1 FY2026 reached ₹10,308.37 crore, marking a substantial increase from ₹8,610.77 crore in the same quarter last year. The company's profit after tax surged to ₹1,589.82 crore, up from ₹1,062.64 crore year-over-year.

On a standalone basis, the company reported revenue from operations of ₹8,821.56 crore, compared to ₹7,578.62 crore in Q1 FY2025. Standalone profit after tax increased to ₹1,519.64 crore from ₹1,085.51 crore in the corresponding quarter of the previous year.

Key Corporate Developments

The Board of Directors has recommended several significant reappointments:

1. Dr. Naresh Trehan has been recommended for reappointment as Chairman and Managing Director for a five-year term starting August 1, 2026.

2. Mr. Vikram Singh Mehta and Mr. Hari Shanker Bhartia have been recommended for reappointment as Independent Directors for second terms of five consecutive years, effective January 25, 2026, and March 23, 2026, respectively.

Dividend and AGM Announcement

Global Health has scheduled its 21st Annual General Meeting (AGM) for September 19, 2025, to be held via video conferencing. The company has set August 22, 2025, as the record date for determining shareholder eligibility for a final dividend of ₹0.50 per equity share for FY2025, subject to shareholder approval at the AGM.

Expansion Plans

During the quarter, Global Health received an offer from Assam Electricity Grid Corporation Limited to acquire a land parcel in Guwahati for establishing a super specialty hospital. The company has subsequently received a revised offer for a 3.5-acre land parcel, indicating potential expansion plans in the northeastern region.

Employee Stock Option Plan

The company has approved the grant of 595,500 options to eligible employees under the Global Health Limited Employees Long-Term Share Based Incentive Plan - 2024. Additionally, 163,000 shares have been allotted to the GHL Employees Welfare Trust as part of this plan.

Global Health's strong financial performance and strategic initiatives demonstrate its commitment to growth and corporate governance, positioning it well for future expansion in the healthcare sector.